Skip to Content

User Reviews for Gemtuzumab to treat Acute Myeloid Leukemia

Also known as: Mylotarg

golfer May 1, 2019

Mylotarg (gemtuzumab): “This is a medicine suggested for my sister who has only a few weeks to live. Will know tomorrow if Dr goes through with this. So scary. He did mentioned about it being taken off the market and now back available. How does one choose?”

Distraught Daughter · Taken for less than 1 month April 18, 2018

Mylotarg (gemtuzumab): “This medicine should be taken off the market. It caused more harm than good. My mother died because of incompetent doctors and Mylotarg. Nothing was changed about the ingredients/composition of this medicine after the FDA approved it to be brought BACK on the market after being taken off for TEN years. It was taken off because it killed more than it saved. Just like it is still doing. The only thing about this medicine that changed when it was brought back in late 2017 was the dosage and how it is administered.”

1 / 10

This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.

Learn more about Acute Myeloid Leukemia

IBM Watson Micromedex

Symptoms and treatments

Mayo Clinic Reference